Cargando…
Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
BACKGROUND: Given the modest responses to everolimus, a mTOR inhibitor, in multiple tumor types, there is a pressing need to identify predictive biomarkers for this drug. Using targeted ultra-deep sequencing, we aimed to explore genomic alterations that confer extreme sensitivity to everolimus. RESU...
Autores principales: | Lim, Sun Min, Park, Hyung Soon, Kim, Sangwoo, Kim, Sora, Ali, Siraj M., Greenbowe, Joel R., Yang, In Seok, Kwon, Nak-Jung, Lee, Jae Lyun, Ryu, Min-Hee, Ahn, Jin-Hee, Lee, Jeeyun, Lee, Min Goo, Kim, Hyo Song, Kim, Hyunki, Kim, Hye Ryun, Moon, Yong Wha, Chung, Hyun Cheol, Kim, Joo-Hang, Kang, Yoon-Koo, Cho, Byoung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891139/ https://www.ncbi.nlm.nih.gov/pubmed/26859683 http://dx.doi.org/10.18632/oncotarget.7234 |
Ejemplares similares
-
Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution
por: Park, Hyung Soon, et al.
Publicado: (2016) -
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
por: Lim, Sun Min, et al.
Publicado: (2016) -
Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014) -
Exceptional mucocutaneous manifestations with amyloid nephropathy: a case report
por: Yoon, Se-Hee, et al.
Publicado: (2018) -
Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)